You have 9 free searches left this month | for more free features.

Apheresis

Showing 1 - 25 of 1,019

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vascular Access Complications for Therapeutic Apheresis in

Recruiting
  • Vascular Access Complication
  • Apheresis Related Complication
    • Nancy, France
      Central Hospital
    May 30, 2023

    Healthy Subjects Trial in El Segundo (N-803)

    Not yet recruiting
    • Healthy Subjects
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Sep 14, 2023

    Citrate Effects and Bone Density in Long-Term Apheresis Donors

    Completed
    • Healthy Apheresis Donors
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 22, 2022

      Fatigue, Post-Acute COVID-19 Syndrome Trial in Hannover (Immunoadsorption vs. sham immunoadsorption)

      Not yet recruiting
      • Fatigue
      • Post-Acute COVID-19 Syndrome
      • Immunoadsorption vs. sham immunoadsorption
      • Hannover, Lower Saxony, Germany
        Hannover Medical School
      Jul 24, 2023

      LDL-Apheresis for FSGS CardioRenal Outcomes

      Enrolling by invitation
      • Focal Segmental Glomerulosclerosis
      • No intervention
      • Cincinnati, Ohio
      • +1 more
      Jan 25, 2023

      Hypercholesterolemia, Familial, Dyslipidemias, Cardiovascular Diseases Trial in Rostock, Dresden (Lipoprotein Apheresis MONET

      Completed
      • Hypercholesterolemia, Familial
      • +2 more
      • Lipoprotein Apheresis MONET and DALI
      • Lipoprotein Apheresis DIAMED and DALI
      • Rostock, Mecklenburg-Vorpommern, Germany
      • +1 more
      Jul 27, 2022

      Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

      Recruiting
      • Granuloma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Tolerance of Therapeutic Apheresis in Paediatric

        Completed
        • Apheresis Related Complication
        • Efficacy of apheresis
        • Montpellier, France
          Uh Montpellier
        Apr 11, 2022

        Stroke, Ischemic Trial in Ulm (CRP apheresis)

        Recruiting
        • Stroke, Ischemic
        • CRP apheresis
        • Ulm, Bayern, Germany
          Abteilung für Neurologie, Universität Ulm
        Mar 8, 2022

        ST Elevation Myocardial Infarction, C-Reactive Protein, Apheresis Trial in Austria, Germany (Selective CRP apheresis using the

        Recruiting
        • ST Elevation Myocardial Infarction
        • +3 more
        • Selective CRP apheresis using the PentraSorb®-CRP system
        • Graz, Austria
        • +4 more
        Jul 11, 2022

        Fluid Loss Trial in Denver (CM-1500)

        Recruiting
        • Fluid Loss
        • CM-1500
        • Denver, Colorado
          Vitalant Blood Donation
        Jun 3, 2022

        Apheresis of Patients With Immunodeficiency

        Recruiting
        • LAD-1
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Aug 24, 2022

          Two is Better Than One: A Novel Venous Access System for

          Recruiting
          • Apheresis
          • PowerPort
          • Chapel Hill, North Carolina
            University of North Carolina at Chapel Hill
          Apr 26, 2022

          Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

          Terminated
          • Decreased Immunologic Activity
          • Antibody-mediated Rejection
          • Combined apheresis
          • Vienna, Austria
            Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
          Aug 22, 2022

          Stroke, Ischemic Trial in Berlin (CRP apheresis)

          Recruiting
          • Stroke, Ischemic
          • CRP apheresis
          • Berlin, Germany
            Zentrum für Schlaganfallforschung (CSB) / Klinik für Neurologie
          Mar 24, 2022

          Bone Density Trial in Milwaukee (high frequency voluntary apheresis blood donation)

          Completed
          • Bone Density
          • high frequency voluntary apheresis blood donation
          • Milwaukee, Wisconsin
            BloodCenter of Wisconsin
          Mar 8, 2022

          Healthy Trial (BioCaptis)

          Not yet recruiting
          • Healthy
          • BioCaptis
          • (no location specified)
          Apr 12, 2023

          Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)

          Recruiting
          • Allogeneic Granulocyte Donation
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 7, 2023

          Hypertriglyceridemia-associated Acute Pancreatitis: Apheresis

          Completed
          • Acute Pancreatitis
          • conservative versus plasmapharesis therapy
          • Kfar Saba, Israel
            Meir Medical Center
          Apr 12, 2022

          Plasma Exchange Trial in Dallas (20-gauge BD Nexiva Diffusics)

          Completed
          • Plasma Exchange
          • 20-gauge BD Nexiva Diffusics
          • Dallas, Texas
            Zale Lipshy Pavilion
          May 11, 2022

          Covid19 Trial in Germany (CRP-apheresis)

          Recruiting
          • Covid19
          • CRP-apheresis
          • Essen, NRW, Germany
          • +3 more
          Mar 29, 2022

          Hyperlipoproteinemia(a) Trial (Pelacarsen (TQJ230) 80 mg s.c., Corresponding Placebo)

          Not yet recruiting
          • Hyperlipoproteinemia(a)
          • Pelacarsen (TQJ230) 80 mg s.c.
          • Corresponding Placebo
          • (no location specified)
          Mar 22, 2022

          Blood Components From Healthy Donors for In Vitro Research Use

          Recruiting
          • Blood Donors
          • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 21, 2023

            Apheresis Related Hypotension Trial in Lakeland, West Des Moines, American Fork (Aurora Xi New Nomogram Software 2.0, Aurora Xi

            Not yet recruiting
            • Apheresis Related Hypotension
            • Aurora Xi New Nomogram Software 2.0
            • Aurora Xi Currently Approved Software 1.3
            • Lakeland, Florida
            • +2 more
            Nov 3, 2023

            Lipoproteinemia, Apheresis Related Complication, Cardiovascular Diseases Trial in Dresden (Dextran sulfate absorption

            Recruiting
            • Lipoproteinemia
            • +2 more
            • Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
            • +3 more
            • Dresden, Germany
              Carl Gustav Carus University Hospital Dresden, Technische Univer
            Dec 20, 2021